Elmiron Lawsuits Filed for Patients with Vision Loss Due to Elmiron Use
In a rush? You can use our Quick Contact Form to tell us the basic information about your case.
We are handling Elmiron lawsuits for patients who have suffered vision loss due to their use of Elmiron. These Elmiron lawsuits are filed against the drug companies responsible for Elmiron. This is because — despite a growing number of Elmiron-related vision loss case reports in the medical literature over the past few years — it was not until June 2020 that any warning about eye problems was included in the Elmiron drug label here in the US.
This Elmiron label change in June 2020 finally added some warnings for serious eye problems such as retinal pigmentary changes and pigmentary maculopathy. From our perspective, these warnings about Elmiron eye side effects were long overdue.
We are currently investigating possible Elmiron lawsuits for patients diagnosed with eye problems such as:
- Vision Loss / Blindness
- Maculopathy (retinal or pigmentation)
- Retinal Pigmentary Endothelium Injury (RPE)
- Pigmentation Maculitis
- Macular Degeneration (pigmentation or dry)
It is important to know that our Elmiron lawsuits for patients who have suffered vision loss are filed only against the pharmaceutical companies responsible for Elmiron — not the doctors who prescribed the Elmiron as a treatment for their bladder diseases.
Significantly, it is not necessary for the patient to have been using Elmiron regularly right up until the time when their Elmiron-related vision loss was diagnosed in order to file an Elmiron lawsuit. That is, unlike most other drug injury cases, the patient could have stopped using Elmiron months before a medical doctor was able to diagnose their eye problem.
Please feel free to contact us if we can be of assistance to you in regards to a possible Elmiron lawsuit.
Free Elmiron Case Evaluation
We encourage you to submit an Elmiron Case Evaluation Form online – it is free, confidential, and there is no obligation. Or, if you prefer, call our toll-free number, (800) 426-9535, to speak directly to attorney Tom Lamb about a possible drug injury case. Either way, you will get Mr. Lamb’s impressions – not an intake person, a paralegal, nor some other lawyer – about your case based on his many years of experience.
Most Recent Article About Elmiron
Elmiron-associated Retinopathy and Other Elmiron Eye Problem Side Effects
For some important details about Elmiron-associated retinopathy and some other Elmiron eye side effects, we point out this excerpt from the Discussion part of this recent Clinical Ophthalmology medical journal article, ” “Pentosan Polysulfate Sodium-Associated Pigmentary Retinopathy: Risk Factors and Fundus Findings”, which was published on December 24, 2021:
To read more of this article, click below:
Some patients with [Pentosan Polysulfate Sodium / Elmiron]-associated retinopathy may unfortunately experience difficulty with dark adaptation, reading, contrast sensitivity, and changes in mesopic microperimetry. In the current study, the [Pentosan Polysulfate Sodium / Elmiron]-associated retinopathy group was more likely to have complaints of difficulty with their visual field, reading, dark adaptation, and visual acuity….
There is currently no treatment for [Pentosan Polysulfate Sodium / Elmiron]-associated maculopathy, and the retinopathy can progress even after discontinuing [Pentosan Polysulfate Sodium / Elmiron]. In a multicenter study of 11 patients who had discontinued [Pentosan Polysulfate Sodium / Elmiron], 77% continued to experience progression, with the RPE atrophy growing at a rate of 0.32mm per year, and 9% developing worsening vision over 12 months…. [footnotes omitted]
We are handling Elmiron lawsuits for patients who have developed Elmiron-associated retinopathy, retinal pigmentary changes, or pigmentary maculopathy due to their past use of Elmiron. These Elmiron lawsuits are filed against the drug companies responsible for Elmiron. This is because — despite a growing number of Elmiron-related vision loss case reports in the medical literature over the years — it was not until June 2020 that any warning about these eye problem side effects was included in the Elmiron drug label here in the US.
It is important to know that our Elmiron lawsuits for patients who have suffered any of these Elmiron eye problem side effects are filed only against the pharmaceutical companies responsible for Elmiron — not the doctors who prescribed the Elmiron as a treatment for their bladder diseases.
Significantly, it is not necessary for the patient to have been using Elmiron regularly right up until the time when their Elmiron-related vision loss was diagnosed in order to file an Elmiron lawsuit. That is, unlike most other drug injury cases, the patient could have stopped using Elmiron months before a medical doctor was able to diagnose their Elmiron-associated retinopathy, for example.
[View article in full at original source]Our earlier articles about Elmiron:
- Elmiron and Maculopathy: Two Recent Medical Articles About an Elmiron Vision Side Effect
- A 2021 Look at the Increased Risk of Elmiron-associated Pigmentary Maculopathy
- New Elmiron Medication Guide Points Out Retinal Pigmentary Eye Problems
- Elmiron Can Double the Risk of Pigmentary Maculopathy or Macular Degeneration
- Maculopathy Patients Should be Asked About Any Elmiron Use in Past
- Elmiron Legal Cases for Eye Damage and Retinal Injury Are Consolidated in Elmiron MDL
- Elmiron Updates: Legal, Medical, and Regulatory – December 2020
- Are Elmiron Side Effects Risks for Eye and Vision Are Greater Than Its Bladder Treatment Benefits?
- Elmiron Lawsuits Being Filed Against Drug Companies for Elmiron-Related Eye Problems
- FDA Announces Elmiron Drug Safety-Related Labeling Changes
- Elmiron Potentially Linked to Severe Eye Disorders